SUVENPHAR Suven Pharmaceuticals Ltd Company Mergers Announcement 2024 - Acquisition Announcement Suven Pharmaceuticals acquires 56% stake in NJ Bio, Inc. for USD 64.4 million to support growth, with a total pre-money valuation of USD 100 million..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd